{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:53:11Z","timestamp":1789095191060,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bmcl.2021.127789","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T14:00:02Z","timestamp":1610632802000},"page":"127789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Bisoprolol-based 18F-PET tracer: Synthesis and preliminary in vivo validation of \u03b21-blocker selectivity for \u03b21-adrenergic receptors in the heart"],"prefix":"10.1016","volume":"36","author":[{"given":"Julie","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal N.","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoung","family":"Pyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerim","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Jo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bmcl.2021.127789_b0005","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/jm2010332","article-title":"Rational approaches to improving selectivity in drug design","volume":"55","author":"Huggins","year":"2012","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2021.127789_b0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1208\/s12248-017-0172-7","article-title":"Target and tissue selectivity prediction by integrated mechanistic pharmacokinetic-target binding and quantitative structure activity modeling","volume":"20","author":"Vlot","year":"2017","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.bmcl.2021.127789_b0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0026-895X(25)11387-4","article-title":"The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro","volume":"16","author":"Mineman","year":"1979","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.bmcl.2021.127789_b0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0014-2999(89)90448-2","article-title":"\u03b2-Adrenoceptors in human brain labelled with [3H]dihydroalprenolol and [3H]CGP 12177","volume":"167","author":"De Paermentier","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2021.127789_b0025","series-title":"Pharmacotherapeutics for advanced practice: a practical approach","author":"Arcangelo","year":"2006"},{"issue":"2","key":"10.1016\/j.bmcl.2021.127789_b0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.HYP.16.2.107","article-title":"Peripheral adrenergic receptors in hypertension","volume":"16","author":"Michel","year":"1990","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.bmcl.2021.127789_b0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0031-6997(25)06662-1","article-title":"\u03b21- and \u03b22-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure","volume":"43","author":"Brodde","year":"1991","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.bmcl.2021.127789_b0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ppedcard.2010.11.007","article-title":"The role of \u03b2-adrenergic receptors in heart failure: differential regulation of cardiotoxicity and cardioprotection","volume":"31","author":"Bernstein","year":"2011","journal-title":"Prog Pediatr Cardiol"},{"issue":"2","key":"10.1016\/j.bmcl.2021.127789_b0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0735-1097(89)90181-2","article-title":"Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta1- and beta2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease","volume":"14","author":"Brodde","year":"1989","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.bmcl.2021.127789_b0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0167-5273(99)00181-3","article-title":"\u03b2-Adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of \u03b21-adrenoceptor density","volume":"72","author":"Anthonio","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.bmcl.2021.127789_b0055","series-title":"Current cardiovascular drugs","author":"Frishman","year":"2005"},{"issue":"5","key":"10.1016\/j.bmcl.2021.127789_b0060","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1476-5381.2010.00754.x","article-title":"The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors","volume":"160","author":"Baker","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.bmcl.2021.127789_b0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0165-6147(97)01138-3","article-title":"The elusive nature of intrinsic efficacy","volume":"19","author":"Clarke","year":"1998","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.bmcl.2021.127789_b0070","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/sj.bjp.0707672","article-title":"Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors","volume":"153","author":"Strange","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.bmcl.2021.127789_b0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","article-title":"The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors","volume":"144","author":"Baker","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.bmcl.2021.127789_b0080","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1096\/fj.201601305R","article-title":"Novel selective \u03b2(1)-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease","volume":"31","author":"Baker","year":"2017","journal-title":"FASEB J"},{"issue":"18","key":"10.1016\/j.bmcl.2021.127789_b0085","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1021\/jm00018a001","article-title":"Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification","volume":"38","author":"Hieble","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127789_b0090","article-title":"Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension","volume":"3","author":"Wong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bmcl.2021.127789_b0095","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00005344-198511001-00002","article-title":"High \u03b21-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol","volume":"8","author":"Haeusler","year":"1985","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.bmcl.2021.127789_b0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0197-0186(00)00049-8","article-title":"Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative \u03b21-selective adrenoceptor radioligand","volume":"38","author":"Soloviev","year":"2001","journal-title":"Neurochem Int"},{"issue":"16","key":"10.1016\/j.bmcl.2021.127789_b0105","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1021\/jm800227h","article-title":"Facile radiosynthesis of fluorine-18 labeled \u03b2-blockers. Synthesis, radiolabeling, and ex vivo biodistribution of [18F]-(2S and 2R)-1-(1-fluoropropan-2-ylamino)-3-(m-tolyloxy)propan-2-ol","volume":"51","author":"Stephenson","year":"2008","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2021.127789_b0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2125.2011.04085.x","article-title":"Positron emission tomography molecular imaging for drug development","volume":"73","author":"Matthews","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.bmcl.2021.127789_b0115","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1007\/s11999-017-5250-8","article-title":"Can spatiotemporal fluoride ((18)F(-)) uptake be used to assess bone formation in the tibia? A longitudinal study using PET\/CT","volume":"475","author":"Lundblad","year":"2017","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"10.1016\/j.bmcl.2021.127789_b0120","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.2967\/jnumed.110.077933","article-title":"Molecular mechanisms of bone 18F-NaF deposition","volume":"51","author":"Czernin","year":"2010","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.bmcl.2021.127789_b0125","doi-asserted-by":"crossref","first-page":"16186","DOI":"10.3390\/molecules200916186","article-title":"Methods to increase the metabolic stability of 18F-radiotracers","volume":"20","author":"Kuchar","year":"2015","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bmcl.2021.127789_b0130","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/acsmedchemlett.9b00235","article-title":"The dark side of fluorine","volume":"10","author":"Pan","year":"2019","journal-title":"ACS Med Chem Lett"},{"issue":"8","key":"10.1016\/j.bmcl.2021.127789_b0135","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1021\/acs.molpharmaceut.0c00523","article-title":"Metabolism of a bioorthogonal PET tracer candidate [19F\/18F]SiFA-tetrazine in mouse liver microsomes: biotransformation pathways and defluorination investigated by UHPLC-HRMS","volume":"17","author":"Otaru","year":"2020","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.bmcl.2021.127789_b0140","first-page":"1665","article-title":"Specific beta-adrenergic receptor binding of carazolol measured with PET","volume":"35","author":"Berridge","year":"1994","journal-title":"J Nucl Med"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:39:24Z","timestamp":1760773164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":28,"alternative-id":["S0960894X21000159"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.127789","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisoprolol-based 18F-PET tracer: Synthesis and preliminary in vivo validation of \u03b21-blocker selectivity for \u03b21-adrenergic receptors in the heart","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.127789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127789"}}